Background: Hepatitis B virus (HBV) infection and hepatocellular carcinoma are major diseases that affect the Taiwanese population. Therefore,
Introduction
Hepatitis B infection and hepatocellular carcinoma represent severe public health problems worldwide, and the HBV is the leading cause of both diseases (Perz et al., 2006; Beasley, 2009 ). Several anti-viral drugs have been certified for the treatment of hepatitis B. However, they cause significant complications such as dose-dependent side-effects and drug resistance. Therefore, novel safe and effective anti-HBV agents are urgently required to treat patients with chronic HBV infection. Several studies have shown that Chinese herbs have the potential to exert antivirus and anticancer effects (Liao et al., 2010; Chen et al., 2011; Wang et al., 2012; Cao et al., 2013) . In this study, we investigated a herb, ICTN, whichdisplays anti-HBV and anti-hepatocellular carcinoma activities.
ICTN is a perennial herb commonly found in Taiwan. It is extensively distributed in the plains and mountains of moderate elevation, and grows on roadsides, ridges, or on uncultivated land. The entire plant contains a milky juice. Taxonomically, it belongs to the Compositae plant family and the Ixeris genus. It exists in Taiwan, the United States, South Korea, Japan, and China. The traditional medical application of ICTN is treatment of pneumonia, bronchitis, and diarrhoea. ICTN displays antipyretic, analgesic, and anti-inflammatory activities, and is used in folk medicine for the treatment of liver disease (Kan, 1981) .
Previous studies have shown that ICTN exerts hepatoprotective effects and can treat liver disease (Qiusheng et al., 2004; Lin et al., 1994) .
In addition to effectively suppressing the hyperplasia of inflammatory human mesangial cells (Kuo et al., 1998) Until now the effects of ICTN on the hepatitis virus and on hepatocellular carcinoma have not been well described. In this study, we observed that ICTN BWE inhibited the secretion of hepatitis B surface antigens and suppressed the growth of hepatocellular carcinoma lines. In addition, the morphology of DAPI-stained cells and DNA fragmentation assay using gel electrophoresis showed clear fragmentation in the chromatin and DNA condensation within the nucleus of cells treated with ICTN BWE, indicating that ICTN BWE suppresses liver cancer cell growth by inducing apoptosis.
Materials and Methods

Preparation of ICTN BWE
An entire ICTN plant was dried in an oven at 45°C for 24 h. A high-speed grinding machine was then used to grind the plant before passing it through a 40-mesh sieve. Ten grams of filtered granular ICTN were placed into 300 mL of 100°C boiling water and heated for 30 min.
Centrifugation was performed after cooling (rotational speed 6 000 rpm, temperature 25 °C) to separate the extract from the plant residues.
Whatman filter paper was then used for filtering, and the filtered crude extract was stored at -84°C overnight. The frozen crude extract was placed in a freeze-dryer, which converted it to a dry powder. Paraffin paper was used to seal and protect the powder from light in a -20°C refrigerator.
This boiling water extract was used in subsequent experiments.
Cell lines and cell culture conditions
Hep3B, which is a human hepatocellular carcinoma cell line and squamous cell carcinoma, contains a chromosome in which the entire hepatitis B virus genome is integrated. It can secrete hepatitis B virus particles, and represents a cell platform for study of the hepatitis B virus.
HuH7 is a human hepatocellular carcinoma cell line and squamous cell carcinoma. This cell line was derived from a tumour from the liver of a 57-year-old Japanese man in 1982. HepG2 is a human hepatocellular carcinoma cell line and hepatoblastoma. It is a human liver cancer cell line with a high degree of differentiation, retaining the cell type of a normal human liver cell. All cell lines were cultivated in a Dulbecco's Modified Eagle's Medium (DMEM; Biowest). A 10% inactivated fetal bovine serum (GIBCO), 100 U/mL penicillin, 100 µg/mL streptomycin, 2 mM L-glutamine, and 1% non-essential amino acid were added to each cell culture and cultivated in a 37°C 5% carbon dioxide cell incubator. When subculturing the cells, a phosphate buffered saline (PBS) was used for washing (twice), and then trypsin-EDTA (Ethylene diamine tetraacetic acid) was applied for 3 to 5 min (the duration differed according to the cell line). This caused the shedding of cells from the petri dish after which they were broken up using pipettes. Finally, the cells were separated into new petri dishes, and a DMEM culture fluid was added.
Hepatitis B virus surface antigens enzyme-linked immunosorbent assay (HBsAg ELISA)
The kit for testing HBsAg (SURASE B-96; TMB) was purchased from the General Biological Corporation of Taiwan, and all experimental steps were performed according to the kit's instruction manual. After incubating ICTN BWE (0, 20, 50, or 100 g/mL) with Hep3B cells for 72 h, the top layer of the culture fluid was extracted for the testing of HBsAg. A 450/650 nm ELISA Plate Reader was used to measure absorbance, and to determine the amount of HBsAg secretion. The number of cells in each group of cells was calculated using haemocytometry. The data obtained from absorbance and the number of cells indicated the relative expression of HBsAg, with the data of the control group assigned as 100% to provide a standard for comparison.
(4) 3-(4,5-Dimethylthiazol-zyl)-2, 5-diphenylterazolium bromide (MTT) assay
Cells were seeded at a density of 3 × 10 5 cells/well in a 6-well cell culture plate, and cultivated for 48 h with ICTN BWE of various concentrations (0 to 0.5 mg/mL). Approximately 0.5 mg/mL MTT was then added to the petri dish and incubated for 4 h. DMSO (Dimethyl sulfoxide) was used to crystallise and dissolve formazan (purple). A spectrophotometer was used at a wavelength of 570 nm to determine the tumour cell survival rate.
Tumour clonogenic assay
Trypsin was used to process the HuH-7 cells into a single cell suspension, which was seeded into a 6-well culture plate at 1000 cells/well.
Triplicate control and drug-treated plates were prepared and cultured for 24 h at 37°C, allowing the cells to attach to the plate. Various concentrations of ICTN BWE (0 to 0.5 mg/mL) were used to treat the cells for 48 h, after which cells were washed 3 times using a PBS. The cells were cultured at 37°C for a further 9 d to allow cell colony formation. After colony formation, the culture liquid was removed and washed 3 times with PBS. A fixative (methanol: acetic acid = 3:1) was used to fix the cells, and a 0.5% crystal violet methanol solution was used for staining. After removal of the dye by washing in water, more than 50 cell colonies were counted under a microscope.
Fluorescence microscopy and DNA electrophoresis
First, cells were seeded to a cover slip. After treating with 350 µg/mL or 500 µg/mL ICTN BWE for 72 h, the cells were rinsed in a PBS and fixed in 4% paraformaldehyde for 15 min. Then, DAPI (1 µg/mL) was added at room temperature for 15 min. A PBS was used for washing, after which cells were mounted in a mounting solution. An inverted fluorescence microscope was used to observe and record the changes in nuclear morphologies. After the collection of groups of cells, a genomic DNA purification kit (QIAGEN, Germany) was used to purify the cell DNA.
Five micrograms of DNA from each group of cells was extracted, and electrophoresis analysis was performed in a 1.8% agarose gel. After using EtBr (ethidium bromide) for staining, the DNA fragments were observed and photographed under a UV light box.
Statistical analysis
Sigma Plot 10.0 statistical software was used for statistical analysis. Data are expressed as mean ± SD, and a paired t-test was used to compare each group with the control group. A p-value < 0.05 was considered significant.
Results
ICTN BWE downregulates HBsAg expression in Hep3B cells
Human Hep3B cells carry multiple copies of HBV DNA that are stably integrated into the host cell genome. They distinctly resemble infected human liver cells, therefore offering a suitable cell system for chronic HBV infection. In this study, we used Hep3B cells as a test platform to evaluate the effects of ICTN BWE on the expression of HBsAg and to elucidate its hepatoprotective mechanisms. Before we tested the effect of ICTN BWE on HBsAg expression in vitro, we first investigated whether ICTN BWE has a direct toxic effect on the Hep3B cell line. 
ICTN BWE inhibits the growth of hepatocellular carcinoma cells
We also investigated whether ICTN BWE has a direct effect on the growth of human liver tumour cells in vitro. HuH-7 and HepG2 human (Figure 2) . The difference between the two cell viabilities is as high as 27.4% at a high concentration (500 µg/mL) of ICTN BWE. 
The cytotoxicity of ICTN BWE to HuH-7 cells was examined with clonogenic assay
Clonogenic assay is an in vitro cell survival assay based on the ability of a single tumour cell to grow into a colony (at least 50 cells). The assay tests every tumour cell in the population for its ability to undergo unlimited division, which is a phenotype of tumour cells. This method is usually used to determine the cytotoxicity of tumour cells exposed to various cytotoxic agents (Franken et al., 2006) . Using a control group assigned as 100% for comparison, our results showed that 500 µg/mL ICTN BWE reduced the colony formation rate of HuH-7 cells to 52.6%, and the inhibitory effect of ICTN BWE on colony formation was dose-dependent ( 
ICTN BWE induces apoptosis in HuH-7 hepatoma cell line in vitro
During apoptosis, endonucleases cleave chromosomal DNA into fragments with a length of approximately 200 bp and multiples. Figure 4A shows the results of a representative experiment in which HuH-7 cells were treated with ICTN BWE at indicated concentrations for 72 h, and genomic DNA were extracted and analysed by DNA electrophoresis. We observed that the control lane contained only high-molecular-weight DNA, but ICTN BWE treatment led to a dose-dependent increase in DNA fragmentation, providing evidence of apoptosis. Next to assess ICTN BWE-induced apoptosis in HuH-7 cells and to examine the influence of ICTN BWE on nuclear apoptotic events, we stained the chromatin of the same treatment groups with DAPI and counted apoptotic nuclei using fluorescence microscopy. Figures 4C and 4D show micrographs of DAPI-stained cells, which have nuclei with fragmented chromatin (white arrow) that are typical for the apoptotic nuclear type. These findings verify that ICTN BWE induces apoptosis in hepatocellular carcinoma cells. 
